Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2020 · 10-Q
Revenue$8.11M$8.11M−1.3% vs Q3 2019 Net Income$784.47K$784.47K−29.7% vs Q3 2019 EPS Diluted$0.10$0.10−23.1% vs Q3 2019 Operating Income$2,480,221+24.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,049,955−23.8% Margins · derivedOperating margin30.6%+6.3 pt vs Q3 2019
Net margin9.7%−3.9 pt vs Q3 2019
ended Aug 31, 2020 · filed Oct 15, 2020 · 45 d after period end